InsidersTradesSigma
Track the Australian Clinical Labs Limited share price and the full management transaction log of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Operating in the Health Care sector, Australian Clinical Labs Limited has logged 15 insider filings. Market capitalisation: €557.7m. The latest transaction was filed on 24 August 2026 (Cease Substantial Holding). Among the most active insiders: There was a change in the interests of the. Every trade is free.
15
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Australian Clinical Labs Limited Buy (bullish), based on 8 analysts. Average price target: A$2.88.
Fundamental score
Ranked 1,651 of 29,064 companies
78.1
score / 100
Value88
Quality69
FCF yld33%
Earn yld6.2%
EV/EBITDA4.3x
ROE15%
Gross mgn83%
Net mgn4.4%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 August 2026
Declarations15 total
ShareASXISIN AU0000148496ASX:2924-03124420-3A699463
ShareASXISIN AU0000148496ASX:2924-03123811-3A699350
ShareASXISIN AU0000148496ASX:2924-03112073-3A697333
ShareASXISIN AU0000148496ASX:2924-03111737-3A697278
●
ShareASXISIN AU0000148496ASX:2924-03092202-3A693702
ShareASXISIN AU0000148496ASX:2924-03092061-3A693677
ShareASXISIN AU0000148496ASX:2924-03086307-3A692634
ShareASXISIN AU0000148496ASX:2924-03082737-3A692020
15 of 15 declarations
Acerca de Australian Clinical Labs Limited
Australian Clinical Labs Limited es una empresa australiana especializada en servicios de laboratorio clínico. Ofrece pruebas de diagnóstico y análisis médicos en todo el país.